SOLVENTUM ($SOLV) posted quarterly earnings results on Thursday, August 7th. The company reported earnings of $1.69 per share, beating estimates of $1.47 by $0.22. The company also reported revenue of $2,161,000,000, missing estimates of $2,161,886,817 by $-886,817.
You can see Quiver Quantitative's $SOLV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SOLVENTUM Hedge Fund Activity
We have seen 271 institutional investors add shares of SOLVENTUM stock to their portfolio, and 491 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INDEPENDENT FRANCHISE PARTNERS LLP added 4,217,570 shares (+263.1%) to their portfolio in Q1 2025, for an estimated $320,704,022
- NUANCE INVESTMENTS, LLC removed 655,847 shares (-48.4%) from their portfolio in Q1 2025, for an estimated $49,870,605
- FMR LLC added 465,460 shares (+44.2%) to their portfolio in Q1 2025, for an estimated $35,393,578
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 432,309 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $32,872,776
- D. E. SHAW & CO., INC. added 413,410 shares (+350.4%) to their portfolio in Q1 2025, for an estimated $31,435,696
- BAUPOST GROUP LLC/MA removed 393,060 shares (-27.2%) from their portfolio in Q1 2025, for an estimated $29,888,282
- CANDLESTICK CAPITAL MANAGEMENT LP added 387,396 shares (+48.3%) to their portfolio in Q1 2025, for an estimated $29,457,591
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SOLVENTUM Government Contracts
We have seen $20,794,688 of award payments to $SOLV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- HICBA ENCODER SOFTWARE AND ASSOCIATED SUPPORT: $12,611,676
- 3M CLINICAL SOFTWARE: $5,629,882
- 3M GPCS SOFTWARE: $1,282,756
- 3M SOFTWARE: $745,055
- 360 ENCOMPASS APPLICATION 3M HEALTH INFORMATION SYSTEMS, INC.:1107926 [25-000090]: $186,110
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
SOLVENTUM Congressional Stock Trading
Members of Congress have traded $SOLV stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SOLV stock by members of Congress over the last 6 months:
- SENATOR RON WYDEN sold up to $15,000 on 02/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
SOLVENTUM Analyst Ratings
Wall Street analysts have issued reports on $SOLV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
- Argus Research issued a "Buy" rating on 07/01/2025
- Piper Sandler issued a "Overweight" rating on 05/19/2025
- Goldman Sachs issued a "Sell" rating on 03/03/2025
To track analyst ratings and price targets for SOLVENTUM, check out Quiver Quantitative's $SOLV forecast page.
SOLVENTUM Price Targets
Multiple analysts have issued price targets for $SOLV recently. We have seen 6 analysts offer price targets for $SOLV in the last 6 months, with a median target of $83.5.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $103.0 on 07/15/2025
- Jason Bednar from Piper Sandler set a target price of $87.0 on 05/19/2025
- Steven Valiquette from Mizuho set a target price of $82.0 on 03/03/2025
- David Roman from Goldman Sachs set a target price of $71.0 on 03/03/2025
- Vik Chopra from Wells Fargo set a target price of $75.0 on 02/28/2025
- Travis Steed from B of A Securities set a target price of $85.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
